DIMENSIONAL FUND ADVISORS LP

Position in TNGX — Tango Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in TNGX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$10,237,159

+$5,921,666 QoQ

Shares Held

489,348

+0.5% QoQ

Ownership

0.338%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 86.7869082943018.ToString("F0")% Shared 4.756533182929122.ToString("F0")% None 8.456558522769072.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. TNGX ranks #74 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,237,159	489,348	+0.5%	Shares	Sole	2026-05-07
2025-12-31	$4,315,493	487,076	-27.6%	Shares	Sole	2026-02-12
2025-09-30	$5,650,972	672,735	+28.1%	Shares	Sole	2025-11-12
2025-06-30	$2,688,501	525,098	-13.2%	Shares	Sole	2025-08-12
2025-03-31	$829,245	605,290	-8.7%	Shares	Sole	2025-05-13
2024-12-31	$2,047,976	662,776	+83.8%	Shares	Sole	2025-02-13
2024-09-30	$2,777,304	360,689	+7.4%	Shares	Sole	2024-11-07
2024-06-30	$2,882,132	335,913	+42.5%	Shares	Sole	2024-08-09
2024-03-31	$1,871,107	235,656	+293.3%	Shares	Sole	2024-05-10
2023-12-31	$593,148	59,914	0.0%	Shares	Sole	2024-02-07
2023-09-30	$674,631	59,914	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.